PREVENTION OF NEPHRITIS IN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II-DEFICIENT MRL-LPR MICE

被引:191
作者
JEVNIKAR, AM
GRUSBY, MJ
GLIMCHER, LH
机构
[1] HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA
[2] UNIV WESTERN ONTARIO, DEPT MED, LONDON N6A 5A5, ONTARIO, CANADA
[3] UNIV WESTERN ONTARIO, DEPT MICROBIOL & IMMUNOL, LONDON N6A 5A5, ONTARIO, CANADA
[4] UNIV WESTERN ONTARIO, ROBARTS RES INST, LONDON N6A 5A5, ONTARIO, CANADA
[5] HARVARD UNIV, SCH PUBL HLTH, DEPT CANC BIOL, BOSTON, MA 02115 USA
关键词
D O I
10.1084/jem.179.4.1137
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
MRL-1pr mice develop aggressive autoimmune kidney disease associated with increased or de novo renal expression of major histocompatibility complex (MHC) class II molecules and a massive systemic expansion of CD4-CD- double negative (DN) T cells. Whereas non-MHC linked genes can have a profound effect on the development of nephritis, lymphadenopathy, and anti-DNA antibody production in MRL-1pr mice, the role of MHC molecules has not been unequivocally established. To study the role of MHC class II in this murine model of systemic lupus erythematosis, class II-deficient MRL-1pr mice (MRL-1pr -/-) were created. MRL-1pr -/- mice developed lymphadenopathy but not autoimmune renal disease or autoantibodies. This study demonstrates that class II expression is critical for the development of autoaggressive CD4+ T cells involved in autoimmune nephritis and clearly dissociates DN T cell expansion from autoimmune disease initiation.
引用
收藏
页码:1137 / 1143
页数:7
相关论文
共 29 条
  • [1] TREATMENT OF (NZBXNZW)F1 DISEASE WITH ANTI-I-A MONOCLONAL-ANTIBODIES
    ADELMAN, NE
    WATLING, DL
    MCDEVITT, HO
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (04) : 1350 - 1355
  • [2] THE DEFECT IN FAS MESSENGER-RNA EXPRESSION IN MRL LPR MICE IS ASSOCIATED WITH INSERTION OF THE RETROTRANSPOSON, ETN
    CHU, JL
    DRAPPA, J
    PARNASSA, A
    ELKON, KB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) : 723 - 730
  • [3] AUTOREACTIVE KIDNEY-INFILTRATING T-CELL CLONES IN MURINE LUPUS NEPHRITIS
    GALLO, CD
    JEVNIKAR, AM
    BRENNAN, DC
    FLORQUIN, S
    PACHECOSILVA, A
    KELLEY, VR
    [J]. KIDNEY INTERNATIONAL, 1992, 42 (04) : 851 - 859
  • [4] GIESE T, 1992, J IMMUNOL, V149, P3097
  • [5] EFFECT OF ANTI-CD4 ANTIBODY TREATMENT ON INFLAMMATORY ARTHRITIS IN MRL-LPR/LPR MICE
    GILKESON, GS
    SPURNEY, R
    COFFMAN, TM
    KURLANDER, R
    RUIZ, P
    PISETSKY, DS
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 64 (02): : 166 - 172
  • [6] DEPLETION OF CD4+ T-CELLS IN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II DEFICIENT MICE
    GRUSBY, MJ
    JOHNSON, RS
    PAPAIOANNOU, VE
    GLIMCHER, LH
    [J]. SCIENCE, 1991, 253 (5026) : 1417 - 1420
  • [7] HERRON LR, 1993, J IMMUNOL, V151, P3450
  • [8] IZUI S, 1984, J IMMUNOL, V133, P227
  • [9] ANTI-CD4 MONOCLONAL-ANTIBODY THERAPY SUPPRESSES AUTOIMMUNE-DISEASE IN MRL/MP-LPR/LPR MICE
    JABS, DA
    BUREK, CL
    HU, Q
    KUPPERS, RC
    LEE, B
    PRENDERGAST, RA
    [J]. CELLULAR IMMUNOLOGY, 1992, 141 (02) : 496 - 507
  • [10] REACTIVE LYMPHOCYTES IN LACRIMAL GLAND AND VASCULITIC RENAL LESIONS OF AUTOIMMUNE MRL/LPR MICE EXPRESS L3T4
    JABS, DA
    PRENDERGAST, RA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (04) : 1198 - 1203